Biggest News Aggregation in the World
📰 Divi Lab News

Page 2 - Divi Lab News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Divi Lab. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Business News | Amid Volatility After Touching an All-time High Sensex, Nifty Close Flat

Get latest articles and stories on Business at LatestLY. The S&P BSE Sensex breached the remarkable 76,000-mark for the first time, hitting 76,010, while the NSE Nifty50 scaled a new summit at 23,111 before retracting into negative territory. Business News | Amid Volatility After Touching an All-time High Sensex, Nifty Close Flat.
United Kingdom New Delhi Piero Cipollone Varun Agarwal Divi Lab Nifty Realty

stock market outlook: Will Nifty hit fresh record high before elections? That depends on these 5 factors

The week may remain lacklustre on the data front as no major economic data releases are scheduled in both the US as well as the Indian market. Indian investors are likely to focus more on the ongoing earnings season as well as stock specific developments. Nifty and Sensex have reached all-time highs driven by US Fed data and expert insights. Key factors that will shape market outlook.
Vipul Bhowar Sun Pharma Jerome Powell Lok Sabha Divi Lab Ashok Leyland

stocks to buy | Aurobindo Pharma | Astral: Nifty at record high? Aditya Agarwala' 2 stock picks

Aditya Agarwala of Invest4edu discusses market insights including key levels for Nifty and Bank Nifty. He anticipates resistance at 50,000 on Bank Nifty and a potential new all-time high for Nifty around 23,000. Aurobindo Pharma is one of his picks. At current levels, one can initiate fresh long in the stock for a target of Rs 1,300 on the upside with a stop loss at Rs 1,120 on the downside. The second stock is Astral. This is one stock which has clearly bucked the trend and has been making hig...
Uttar Pradesh Aditya Agarwala Maruti Suzuki Aurobindo Pharma Divi Lab Ashok Leyland

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science